Anti-topoisomerase I autoantibodies in systemic sclerosis

Autoimmunity Reviews

Volumn 8, Issue 8, 2009, Pages 692-696

  Czömpöly, Tamás ^a   Simon, Diána ^a   Czirják, László ^a   Németh, Péter ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Anti topoisomerase I; Autoantibodies; Epitope mapping; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; DNA TOPOISOMERASE; NUCLEAR PROTEIN; SCL 70 ANTIBODY;

ANTIBODY DETECTION; ANTIGENICITY; DISEASE ASSOCIATION; DNA STRAND BREAKAGE; EPITOPE MAPPING; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; LUNG FIBROSIS; PREVALENCE; PROTEIN FAMILY; REVIEW; SKIN FIBROSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULAR FIBROSIS;

AUTOANTIBODIES; DNA TOPOISOMERASES, TYPE I; EPITOPE MAPPING; HUMANS; NUCLEAR PROTEINS; SCLERODERMA, SYSTEMIC;

EID: 67349220661     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.018     Document Type: Review

References (40)

1. Varga J., and Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117 (2007) 557-567
2. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger Jr. T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15 (1988) 202-205
3. Walker U.A., Tyndall A., Czirják L., Denton C., Farge-Bancel D., Kowal-Bielecka O., et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 66 (2007) 754-763
4. Johnson S.R., Feldman B.M., and Hawker G.A. Classification criteria for systemic sclerosis subsets. J Rheumatol 34 (2007) 1855-1863
5. Okano Y. Antinuclear antibody in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 22 (1996) 709-735
6. Koenig M., Dieudé M., and Senécal J.L. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies. Autoimmun Rev 7 (2008) 588-593
7. Walker J.G., and Fritzler M.J. Update on autoantibodies in systemic sclerosis. Curr Opin Rheumatol 19 (2007) 580-591
8. Champoux J.J. Strand breakage by the DNA untwisting enzyme results in covalent attachment of the enzyme to DNA. Proc Natl Acad Sci U S A 74 (1977) 3800-3804
9. Liu L.F., Liu C.C., and Alberts B.M. Type II DNA topoisomerases: enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break. Cell 19 (1980) 697-707
10. Douvas A.S., Achten M., and Tan E.M. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem 254 (1979) 10514-10522
11. Shero J.H., Bordwell B., Rothfield N.F., and Earnshaw W.C. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science 231 (1986) 737-740
12. Gussin H.A., Ignat G.P., Varga J., and Teodorescu M. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 44 (2001) 376-383
13. Hamidou M.A., Audrain M.A., Masseau A., Agard C., and Moreau A. Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis. Clin Rheumatol 25 (2006) 542-543
14. Grigolo B., Mazzetti I., Meliconi R., Bazzi S., Scorza R., Candela M., et al. Anti-topoisomerase II autoantibodies in systemic sclerosis: association with pulmonary hypertension and HLA-B35. Clin Exp Immunol 121 (2000) 539-543
15. Hayakawa I., Hasegawa M., Takehara K., and Sato S. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma. Arthritis Rheum 50 (2004) 227-232
16. Meliconi R., Bestagno M., Sturani C., Negri C., Galavotti V., Sala C., et al. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol 76 (1989) 184-189
17. Hoffmann A., Heck M.M., Bordwell B.J., Rothfield N.F., and Earnshaw W.C. Human autoantibody to topoisomerase II. Exp Cell Res 180 (1989) 409-418
18. Zuklys K.L., Szer I.S., and Szer W. Autoantibodies to DNA topoisomerase II in juvenile rheumatoid arthritis. Clin Exp Immunol 84 (1991) 245-249
19. Chang Y.H., Hwang J., Shang H.F., and Tsai S.T. Characterization of human DNA topoisomerase II as an autoantigen recognized by patients with IDDM. Diabetes 45 (1996) 408-414
20. Hildebrandt S., Weiner E., Senecal J.L., Noell S., Daniels L., Earnshaw W.C., et al. The IgG, IgM, and IgA isotypes of antitopoisomerase-1 and anticentromere autoantibodies. Arthritis Rheum 33 (1990) 724-727
21. Reveille J.D., Solomon D.H., and the American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70 and nucleolar antibodies. Arthritis Rheum 49 (2003) 399-412
22. Steen V.D., Powell D.L., and Medsger Jr. T.A. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31 (1988) 196-203
23. Kuwana M., Kaburaki J., Okano Y., Tojo T., and Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 37 (1994) 75-83
24. Hu P.Q., Fertig N., Medsger Jr. T.A., and Wright T.M. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and disease activity in SSc. Arthritis Rheum 48 (2003) 1363-1373
25. Redinbo M.R., Stewart L., Kuhn P., Champoux J.J., and Hol W.G. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279 (1998) 1504-1513
26. Verheijen R., Van Den Hoogen F., Beijer R., Richter A., Penner E., Habets W.J., et al. A recombinant topoisomerase I used for autoantibody detection in sera from patients with systemic sclerosis. Clin Exp Immunol 80 (1990) 38-43
27. D'Arpa P., White-Cooper H., Cleveland D.W., Rothfield N.F., and Earnshaw W.C. Use of molecular cloning methods to map the distribution of epitopes on topoisomerase I (Scl-70) recognized by sera of scleroderma patients. Arthritis Rheum 33 (1990) 1501-1511
28. Kuwana M., Kaburaki J., Mimori T., Tojo T., and Homma M. Autoantigenic epitopes on DNA topoisomerase I: clinical and immunogenetic associations in systemic sclerosis. Arthritis Rheum 36 (1993) 1406-1413
29. Piccinini G., Cardellini E., Reimer G., Arnett F.C., and Durban E. An antigenic region of topoisomerase I in DNA polymerase chain reaction-generated fragments recognized by autoantibodies of scleroderma patients. Mol Immunol 28 (1991) 333-339
30. Hu P.Q., Fertig N., Medsger Jr. T.A., and Wright T.M. Molecular recognition patterns of serum anti-DNA topoisomerase I antibody in systemic sclerosis. J Immunol 173 (2004) 2834-2841
31. Rizou C., Ioannidis J.P., Panou-Pomonis E., Sakarellos-Daitsiotis M., Sakarellos C., Moutsopoulos H.M., et al. B-cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis. Am J Respir Cell Mol Biol 22 (2000) 344-351
32. Meesters T.M., Hoet M., Van Den Hoogen F.H., Verheijen R., Habets W.J., and Van Venrooij W.J. Analysis of an immunodominant epitope of topoisomerase I in patients with systemic sclerosis. Mol Biol Rep 16 (1992) 117-123
33. Simon D, Czompoly T, Berki T, Minier T, Peti A, Toth E, Czirják L, Nemeth P. Naturally occurring and disease associated autoantibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus. Int Immunol 2009 (Accepted for publication).
34. Weiner E.S., Hildebrandt S., Senecal J.L., Daniels L., Noell S., Joyal F., et al. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease: a prospective study. Arthritis Rheum 34 (1991) 68-77
35. Gabrielli A., Svegliati S., Moroncini G., Luchetti M., Tonnini C., and Avvedimento E.V. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets. Autoimmun Rev 7 (2007) 121-126
36. Baroni S.S., Santillo M., Bevilacqua F., Luchetti M., Spadoni T., Mancini M., et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354 (2006) 2667-2676
37. Balada E., Simeón-Aznar C.P., Ordi-Ros J., Rosa-Leyva M., Selva-O'Callaghan A., Pardos-Gea J., et al. Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosis. Ann Rheum Dis 67 (2008) 1027-1029
38. Hénault J., Tremblay M., Clément I., Raymond Y., and Senécal J.L. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 50 (2004) 3265-3274
39. Hénault J., Robitaille G., Senécal J.L., and Raymond Y. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum 54 (2006) 963-973
40. Guiducci S., Giacomelli R., and Cerinic M.M. Vascular complications of scleroderma. Autoimmun Rev 6 (2007) 520-523